Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directorate Change

23rd Dec 2009 15:55

RNS Number : 6704E
Proteome Sciences PLC
23 December 2009
 



Proteome Sciences plc 

("Proteome Sciences" or "the Company")

Resignation of Director 

and 

Appointment of Chief Operating Officer

23rd December 2009: The Board of Proteome Sciences announces that Dr. Peter Schulz-Knappe will be leaving Proteome Sciences R&D GmbH & Co. KG on 31st December 2009 in order to be based more closely to his family, at which point he will resign as a director from the Company. The directors would like to thank Dr. Schulz-Knappe for his considerable contribution to the Company's progress and wish him every success in the future.

The Company is pleased to announce that Dr. Ian Pike has been appointed Chief Operating Officer of the Company and its subsidiaries and that Dr. Hans-Dieter Zucht has been appointed as Chief Technical Officer of Proteome Sciences R&D GmbH Co. KG in Frankfurt. Neither of these are appointments to the board of Proteome Sciences.

Ends

For further information please contact: 

Proteome Sciences plc

www.proteomics.com

Tel: +44 (0)1932 865065

Christopher Pearce, Chief Executive

James Malthouse, Finance Director 

Dr. Ian Pike, Chief Operating Officer

Email: [email protected]

Email: [email protected]

Email: [email protected]

Public Relations

IKON Associates 

Adrian Shaw

Tel: +44 (0)1483 271291

Mobile: +44 (0)797 9900733

Email: [email protected]

Redleaf Communications Ltd. 

Samantha Robbins / Anna Dunkin 

Tel: +44 (0)20 7566 6700

Email: [email protected]

Nominated Adviser

Noble & Company Ltd.

John Llewellyn-Lloyd

Tel: +44 (0)20 7763 2200

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAEXLFLKLBEFBZ

Related Shares:

Proteome
FTSE 100 Latest
Value8,474.74
Change-133.74